Published in Antimicrob Agents Chemother on November 01, 1997
Aminoglycosides: activity and resistance. Antimicrob Agents Chemother (1999) 3.11
Acquired antibiotic resistance genes: an overview. Front Microbiol (2011) 2.80
Structure-based phylogenies of the serine beta-lactamases. J Mol Evol (2003) 0.99
Erratum: Acquired antibiotic resistance genes: an overview. Front Microbiol (2012) 0.81
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res (1984) 181.98
Nucleotide sequence of the kanamycin resistance transposon Tn903. J Mol Biol (1981) 12.25
Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes. Microbiol Rev (1993) 9.38
Mobile gene cassettes and integrons: capture and spread of genes by site-specific recombination. Mol Microbiol (1995) 7.12
Expression of antibiotic resistance genes in the integrated cassettes of integrons. Antimicrob Agents Chemother (1995) 6.26
The partial 3'-conserved segment duplications in the integrons In6 from pSa and In7 from pDGO100 have a common origin. Plasmid (1993) 2.87
New mobile gene cassettes containing an aminoglycoside resistance gene, aacA7, and a chloramphenicol resistance gene, catB3, in an integron in pBWH301. Antimicrob Agents Chemother (1995) 2.41
Nucleotide sequence of Escherichia coli katE, which encodes catalase HPII. J Bacteriol (1991) 2.30
Isolation, characterization, and DNA sequence analysis of an AAC(6')-II gene from Pseudomonas aeruginosa. Antimicrob Agents Chemother (1989) 2.08
Sequencing and expression of the 6'-N-acetyltransferase gene of transposon Tn1331 from Klebsiella pneumoniae. J Bacteriol (1988) 2.07
Characterization of the chromosomal aac(6')-Ic gene from Serratia marcescens. Antimicrob Agents Chemother (1992) 1.97
Nucleotide sequence of the aacC2 gene, a gentamicin resistance determinant involved in a hospital epidemic of multiply resistant members of the family Enterobacteriaceae. Antimicrob Agents Chemother (1989) 1.66
Genetic analysis of bacterial acetyltransferases: identification of amino acids determining the specificities of the aminoglycoside 6'-N-acetyltransferase Ib and IIa proteins. J Bacteriol (1992) 1.64
Correlation between aminoglycoside resistance profiles and DNA hybridization of clinical isolates. Antimicrob Agents Chemother (1991) 1.62
Resistance towards aminoglycoside-aminocyclitol antibiotics in bacteria. J Antimicrob Chemother (1981) 1.58
Characterization of the chromosomal aac(6')-Ij gene of Acinetobacter sp. 13 and the aac(6')-Ih plasmid gene of Acinetobacter baumannii. Antimicrob Agents Chemother (1994) 1.39
Nucleotide sequence of the transposable element IS15. Gene (1984) 1.33
The kanamycin resistance transposon Tn2680 derived from the R plasmid Rts1 and carried by phage P1Km has flanking 0.8-kb-long direct repeats. Plasmid (1982) 1.16
The Pseudomonas putida ML2 plasmid-encoded genes for benzene dioxygenase are unusual in codon usage and low in G+C content. Gene (1993) 1.12
Characterization of the aac(6')-Ik gene of Acinetobacter sp. 6. FEMS Microbiol Lett (1994) 1.06
IS15, a new insertion sequence widely spread in R plasmids of gram-negative bacteria. Mol Gen Genet (1983) 1.05
Cointegrational transduction and mobilization of gentamicin resistance plasmid pWP14a is mediated by IS140. Mol Gen Genet (1983) 1.01
More than one DNA sequence encodes the 2''-O-adenylyltransferase phenotype. Antimicrob Agents Chemother (1987) 0.92
Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes. Microbiol Rev (1993) 9.38
Escherichia coli K-12 auxotrophs induced by insertion of the transposable element Tn5. Genetics (1979) 5.49
Antibiotic susceptibility profiles of Escherichia coli strains lacking multidrug efflux pump genes. Antimicrob Agents Chemother (2001) 3.87
Biological activity of netilmicin, a broad-spectrum semisynthetic aminoglycoside antibiotic. Antimicrob Agents Chemother (1976) 3.26
THE EFFECT OF CAFFEIN SODIO-BENZOATE, THEO-BROMIN SODIO-SALICYLATE, THEOPHYLLIN AND EUPHYLLIN ON THE CORONARY FLOW AND CARDIAC ACTION OF THE RABBIT. J Clin Invest (1925) 2.89
Comparison of aminoglycoside resistance patterns in Japan, Formosa, and Korea, Chile, and the United States. Antimicrob Agents Chemother (1985) 2.66
Effects of altered 5'-flanking sequences on the in vivo expression of a Saccharomyces cerevisiae tRNATyr gene. Mol Cell Biol (1984) 2.35
The life expectancy of nonsmoking men and women. Public Health Rep (1983) 2.34
In vitro and in vivo activities of SCH 56592 (posaconazole), a new triazole antifungal agent, against Aspergillus and Candida. Antimicrob Agents Chemother (2000) 2.33
Antibiotic susceptibility of multiply resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis, including candidates for transplantation. Clin Infect Dis (1996) 2.23
The most frequent aminoglycoside resistance mechanisms--changes with time and geographic area: a reflection of aminoglycoside usage patterns? Aminoglycoside Resistance Study Groups. Clin Infect Dis (1997) 2.14
Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy. Proc Natl Acad Sci U S A (1995) 2.11
Enzymatic modification of aminoglycoside antibiotics: a new 3-N-acetylating enzyme from a Pseudomonas aeruginosa isolate. Antimicrob Agents Chemother (1976) 2.10
Isolation, characterization, and DNA sequence analysis of an AAC(6')-II gene from Pseudomonas aeruginosa. Antimicrob Agents Chemother (1989) 2.08
Physiological characterization of polar Tn5-induced isoleucine-valine auxotrophs in Escherichia coli K.12: evidence for an internal promoter in the ilvOGEDA operon. Genetics (1979) 2.07
Characterization of the chromosomal aac(6')-Ic gene from Serratia marcescens. Antimicrob Agents Chemother (1992) 1.97
Reversible peripartum liver failure: a new perspective on the diagnosis, treatment, and cause of acute fatty liver of pregnancy, based on 28 consecutive cases. Am J Obstet Gynecol (1999) 1.92
Salmonella typhimurium mutants defective in acetohydroxy acid synthases I and II. J Bacteriol (1980) 1.87
Cardiotrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor/gp130 signaling complex. J Biol Chem (1995) 1.83
Dating pleistocene archeological sites by protein diagenesis in ostrich eggshell. Science (1990) 1.76
Use of plasmid analysis and determination of aminoglycoside-modifying enzymes to characterize isolates from an outbreak of methicillin-resistant Staphylococcus aureus. J Clin Microbiol (1989) 1.74
Pharmacokinetics of SCH 56592, a new azole broad-spectrum antifungal agent, in mice, rats, rabbits, dogs, and cynomolgus monkeys. Antimicrob Agents Chemother (2000) 1.64
Genetic analysis of bacterial acetyltransferases: identification of amino acids determining the specificities of the aminoglycoside 6'-N-acetyltransferase Ib and IIa proteins. J Bacteriol (1992) 1.64
A novel gentamicin resistance gene in Enterococcus. Antimicrob Agents Chemother (1997) 1.63
Correlation between aminoglycoside resistance profiles and DNA hybridization of clinical isolates. Antimicrob Agents Chemother (1991) 1.62
Chemotherapeutic evaluation of 5-episisomicin (Sch 22591), a new semisynthetic aminoglycoside. Antimicrob Agents Chemother (1978) 1.61
Cancer, passive smoking and nonemployed and employed wives. West J Med (1984) 1.59
Appearance of amikacin and tobramycin resistance due to 4'-aminoglycoside nucleotidyltransferase [ANT(4')-II] in gram-negative pathogens. Antimicrob Agents Chemother (1990) 1.59
Detection of the high-level aminoglycoside resistance gene aph(2")-Ib in Enterococcus faecium. Antimicrob Agents Chemother (2000) 1.57
Synthesis, characterization, and structure-activity relationships of amidine-substituted (bis)benzylidene-cycloketone olefin isomers as potent and selective factor Xa inhibitors. J Med Chem (1999) 1.56
The ilvG gene is expressed in Escherichia coli K-12. Gene (1980) 1.40
Characterization and transcriptional regulation of the 2'-N-acetyltransferase gene from Providencia stuartii. J Bacteriol (1993) 1.36
Genomics and antimicrobial drug discovery. Antimicrob Agents Chemother (1999) 1.35
Mutations in ribosomal protein L16 conferring reduced susceptibility to evernimicin (SCH27899): implications for mechanism of action. Antimicrob Agents Chemother (2000) 1.32
Renal pharmacology of netilmicin. Antimicrob Agents Chemother (1977) 1.29
Cloning and characterization of KNR4, a yeast gene involved in (1,3)-beta-glucan synthesis. Mol Cell Biol (1994) 1.28
Aminoglycoside-resistance mechanisms for cystic fibrosis Pseudomonas aeruginosa isolates are unchanged by long-term, intermittent, inhaled tobramycin treatment. J Infect Dis (2000) 1.27
Influence of cation supplements on activity of netilmicin against Pseudomonas aeruginosa in vitro and in vivo. Antimicrob Agents Chemother (1987) 1.26
Evernimicin binds exclusively to the 50S ribosomal subunit and inhibits translation in cell-free systems derived from both gram-positive and gram-negative bacteria. Antimicrob Agents Chemother (2000) 1.23
Organization and regulation of the ilvGEDA operon in Salmonella typhimurium LT2. J Bacteriol (1981) 1.22
Distribution of bromophenols in species of marine algae from eastern Australia. J Agric Food Chem (1999) 1.21
Surface-active substrates for Raman and luminescence analysis. Talanta (2008) 1.20
Evernimicin (SCH27899) inhibits a novel ribosome target site: analysis of 23S ribosomal DNA mutants. Antimicrob Agents Chemother (2000) 1.19
EmtA, a rRNA methyltransferase conferring high-level evernimicin resistance. Mol Microbiol (2001) 1.17
Sulfonamide structure-activity relationships in a cell-free system. 2. Proof for the formation of a sulfonamide-containing folate analog. J Med Chem (1974) 1.15
Kinetics and mechanisms of action of antibiotics on microorganisms. V. Chloramphenicol and tetracycline affected Escherichia coli generation rates. J Pharm Sci (1966) 1.15
Improved synthesis of the sodium salt of DL-alpha, beta-dihydroxyisovaleric acid. Anal Biochem (1980) 1.14
Biological activity of SCH 21420, the 1-N-S-alpha-hydroxy-beta-aminopropionyl derivative of gentamicin B. J Antibiot (Tokyo) (1978) 1.13
The changing nature of aminoglycoside resistance mechanisms and prevalence of newly recognized resistance mechanisms in Turkey. Clin Microbiol Infect (2001) 1.12
Genetic footprinting in bacteria. J Bacteriol (2001) 1.11
Identification of three additional femAB-like open reading frames in Staphylococcus aureus. FEMS Microbiol Lett (1999) 1.10
The syntheses and biological properties of 1-N-(S-4-amino-2-hydroxybutyryl)-gentamicin B and 1-N-(S-3-amino-2-hydroxypropionyl)-gentamicin B. J Antibiot (Tokyo) (1978) 1.10
Chemical modification of everninomicins. J Antibiot (Tokyo) (1982) 1.10
In vitro and in vivo activities of SCH 42427, the active enantiomer of the antifungal agent SCH 39304. Antimicrob Agents Chemother (1992) 1.08
Aminoglycoside resistance genes aph(2")-Ib and aac(6')-Im detected together in strains of both Escherichia coli and Enterococcus faecium. Antimicrob Agents Chemother (2001) 1.07
Cloning and characterization of a 3-N-aminoglycoside acetyltransferase gene, aac(3)-Ib, from Pseudomonas aeruginosa. Antimicrob Agents Chemother (1995) 1.07
Substrate channeling: alpha-ketobutyrate inhibition of acetohydroxy acid synthase in Salmonella typhimurium. J Bacteriol (1980) 1.07
The Ledermann model of alcohol consumption. Description, implications and assessment. Q J Stud Alcohol (1974) 1.06
Disseminated intravascular coagulation and antithrombin III depression in acute fatty liver of pregnancy. Am J Obstet Gynecol (1996) 1.06
Radiologic studies in acute fatty liver of pregnancy. A review of the literature and 19 new cases. J Reprod Med (1996) 1.02
Cloning and DNA sequence analysis of an aac(3)-Vb gene from Serratia marcescens. Antimicrob Agents Chemother (1992) 1.02
Lactation and genital involution effects of a new low-dose oral contraceptive on breast-feeding mothers and their infants. Obstet Gynecol (1970) 1.01
Gram-negative bacilli resistant to third-generation cephalosporins: beta-lactamase characterization and susceptibility to Sch 34343. J Antimicrob Chemother (1985) 1.01
Kinetics and mechanisms of action of trimethoprim and sulfonamides, alone or in combination, upon Escherichia coli. Chemotherapy (1972) 1.01
Comparison of SCH 39304, fluconazole, and ketoconazole for treatment of systemic infections in mice. Antimicrob Agents Chemother (1992) 1.00
Resistance to aminoglycoside antibiotics in gram-negative bacilli and staphylococci isolated from blood. Report from a European collaborative study. The ESGAR Study Group (European Study Group on Antibiotic Resistance). J Antimicrob Chemother (1990) 0.99
Pulmonary hemorrhage and glomerulonephritis. Treatment of two cases by bilateral nephrectomy and renal transplantation. Arch Surg (1968) 0.99
Sulfonamide structure-activity relationship in a cell-free system. Correlation of inhibition of folate synthesis with antibacterial activity and physicochemical parameters. J Med Chem (1972) 0.98
In vitro Gram-positive antimicrobial activity of evernimicin (SCH 27899), a novel oligosaccharide, compared with other antimicrobials: a multicentre international trial. J Antimicrob Chemother (2001) 0.97
Analysis of beta-glucans and chitin in a Saccharomyces cerevisiae cell wall mutant using high-performance liquid chromatography. Yeast (1994) 0.96
Revision of standards for adjusting the cation content of Mueller-Hinton broth for testing susceptibility of Pseudomonas aeruginosa to aminoglycosides. J Clin Microbiol (1992) 0.96
Modification of interpretive breakpoints for netilmicin disk susceptibility tests with Pseudomonas aeruginosa. J Clin Microbiol (1984) 0.96